**Charity number: 1140271 Company number: 7378488** 

**Bowel Cancer West** 

**(A company limited by guarantee)** 

**Trustees' report and financial statements** 

**for the period ended 31 December 2025** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Contents** 

||**Page**|
|---|---|
|Legal and administrative information|**1**|
|Trustees' report|**2 - 5**|
|Independent examiners' report|**6**|
|Statement of financial activities|**7**|
|Balance sheet|**8 - 9**|
|Notes to the financial statements|**10 - 17**|





## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025** 

**Charity number** 1140271 **Company registration number** 7378488 **Business address and Registered office** Best Accountancy Services (Plymouth) Limited Unit 7, Seaton Business Park 36 William Prance Road Plymouth PL6 5WR **Directors/Committee** Mr M Coleman Chairman Mr J Best Treasurer Mr J Mills (resigned 31[st] October 2025) Ms D Sheppard (Vice Chair) Mrs S Coleman Ms S Davarian Mr H Mckenzie Mr G Pattison Mr P Menis Mrs N Fishwick (appointed 15[th] July 2026) **Accountants** Best Accountancy Services (Plymouth) Ltd Unit 7, Seaton Business Park 36 William Prance Road Plymouth PL6 5WR **Bankers** National Westminster Bank plc 

**Page 1** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025** 

The trustees present their report and the financial statements for the year ended 31 December 2025. The trustees, who are also directors of Bowel Cancer West for the purposes of company law and who served during the year and up to the date of this report are set out on page 1. 

## **Structure, governance and management** 

Structure, governance and management Bowel Cancer West is a registered charity, number 1140271 and is constituted under The Companies Act 2006 as a Private Company Limited by Guarantee and governed by the Articles of Association of Bowel Cancer West. Company number 7378488. 

The charity was established in 2010 for research and education in the specialty of bowel cancer, and for developing the public awareness of the disease in the west of England. The charity's strap-line Awareness, Research, Training tries to capture this. The charity's main aim is to improve survival rates of people with bowel cancer in the southwest of the UK. New directors are appointed by the existing directors. Retirement of directors is by rotation at the Annual General Meeting in accordance with the Memorandum and Articles of Association. The Articles of Association provides for a minimum of 3 directors but shall not be subject to any maximum. 

The overall responsibility for the work of the charity lies with the Board of Trustees who help shape the strategy and approve plans to deliver the Charity's aims. Progress is monitored and evaluated at board meetings (every 2-3 months) where the board receive regular reports from the Executive Director or Vice Chair. 

A new part-time Chief Executive (Caroline Bramwell) was appointed in February 2025, however she resigned with the support of the Board, as the financial objectives were not met. The role reverted to Diane Sheppard, Vice-Chair as an unpaid part-time role. From August 2025 there are no paid employees within the charity, meaning that all funds raised entirely support the charities aims. 

A financial statement and strategic update is prepared and presented to the Board along with papers to enable Board members to comment if they are unable to attend the meeting. Careful stewardship of the charity's resources is a key element of the meeting. All directors give their time freely. An expe nse claim policy is in place and any payments made are shown through the accounts. Directors are required to disclose all relevant interests and register them with the Chair and in accordance with the Articles of Association withdraw from decisions where a conflict of interest arises. The directors long term aim is to ensure that membership is well balanced from a clinical and business perspective as well as that of people who have experienced bowel cancer. Clinical representation is reflected in the appointment of the Chairman who is a consultant surgeon and Vice Chair who is a senior nurse.  Trustee appointments that enable local networking and establish the charity within the business community are also vital for the charity’s success. 

## _Risk management_ 

Key risks include the support of research projects.  A Sub-committee is consulted around the appropriateness of the funding.  Integral to this is the need for ethical approval from the associated hospital trust or university research and development department.  Any such studies will require a 'sponsor' which will usually be the hospital trust or university. The sponsor then provides the indemnity for the research project and although Bowel Cancer West provides the funding for the research project it is free of any contingent liability. Funding will not be released until proof of ethical approval and sponsorship is provided by the candidate. The candidate is required to document and record such approvals and to provide progress updates to Bowel Cancer West and the Sponsor. 

Bowel Cancer West has public liability insurance. Risk assessments are undertaken as necessary, for example the use of the smoothie bike. 

The charity shop had health and safety and fire risk assessments undertaken on a regular basis by the shop manager who reported the outcome and need for action to the Vice Chair.  Appropriate vetting of volunteers working in the shop. 

**Page 2** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025** 

## **Objectives and activities** 

The Directors confirm that they have referred to the guidance contained in the Charity Commission's general guidance on the public benefit when reviewing the charity's aims and objectives and in planning future activities and setting the grant making policy for the year. 

A new strategy was agreed with the Board on an away day in October 2024 with input from an expert in bowel cancer and screening to challenge the directors in their thinking.  The aim is to try and ensure that awareness raising is prioritised in areas where there is a lower return rate of national bowel screening and higher incidence of bowel cancer 

## **Achievements and performance** 

The Board took the decision at the beginning of 2025 to close the charity shop when the three-year shop lease was due for renewal in May 2025.  Due to increasing running costs such as utilities, rates and minimum wages, the cost of running the shop was higher than the income received, even though the shop was very well supported in the local community. 

The remaining stocks and assets were decanted to a smaller unit and sold through various fares and online.  The unit was rented for 6 months with notice given in October 2025. 

For the fourth year running the charity has assisted with the running of the Devon and Cornwall Backyard Ultra, which is an endurance running event which was held in Newnham Park, Plymouth in August.  The event was supported by our Treasurer John Best who successfully attracted runners and sponsors for the event, which generated a substantial profit for the charity as well as promoting the importance of fitness is supporting the prevention of bowel cancer. A separate website is established for this event focusing on the running community. 

The charities website was totally revamped over 2025, with a company’s time purchased assist with the ongoing maintenance of the website. 

## Research 

Bowel Cancer West has partnered with the University of Cardiff to fund research into LARS.  LARS (Lower Anterior Resection Syndrome) can be a complication for patients who have had part of their rectum removed from cancer. The project has resulted in the production of educational resources for patients and clinicians and the management techniques that are available and most suitable for their symptoms. 

## Training 

No funding has been allocated for training due to the current financial pressures associated with the hospital shop and appointment of a chief executive.  Plans are in place to start funding training during 2026. 

## Awareness 

Awareness events included Liskeard Show, Yealmpton Show and Devon County Show all of which have a large football of many thousands of people.  There are many people attending from the farming community.  Farmers are believed to be quite stoical when it comes to their health and therefore raising awareness and the importance of early intervention if you experience symptoms is key to a successful and swift outcome enabling them to return to work. 

Awareness raising to carers in Devon has been a focus in partnership with the Wellmore.  Several meetings were held across the county talking to carers about bowel cancer and recognising symptoms and the benefits of early diagnosis. 

The charity continues to be supported by local organisations nominating the charity as their charity of the year and by people who raise funds through sponsored running events. 

**Page 3** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025** 

## BCW Team Members 

Our fund raising and events lead resigned in February 2025 and due to issues with finances it was agreed to not replace her but continue with the Chief Executive.  As mentioned previously the Chief Executive also resigned in August 2025. With the closure of the shop this has given the opportunity for the finances to recover. 

The team is very well supported by a voluntary administrator who supports the team ensuring Board meetings are organised and recorded and that awareness materials are available and administers research requests as well as paying invoices and banking income. 

## **Financial review** 

In the 2025 financial year funds deployed by the charity (excluding governance costs) were £48,685 in the previous 12 months it was £75,344.  The funding was spent on charitable activity expenditure of £48,685. There were no awareness or training costs in the period. 

The closure of the shop proved to be a positive decision as no longer a drain on resources. 

The ongoing cost of living in the UK has made fundraising a tough thing to achieve in 2025 however the Committee and volunteers worked very hard to attend and run various throughout the year. 

The trustees’ have been cautious in the year and have managed the funds available well in trying to make best use of the resources. The trustees also took the difficult decision to terminate the employment of the CEO with the cost of employment being higher than the level of income being realised. The charity required a complete reset, strip and simplify to ensure its survival. 

Overall, a loss was realised in 2025 of £7,858. 

At the end of 2025 we had unfettered cash reserves of £27,611 compared to £35,469 last year. 

## **Plans for future periods** 

For 2026 BCW is concentrating on consolidation, with the removal of unnecessary expenses. In tandem, its strategic approach is to: 

- Increase support through online and in-person groups 

- To fund research up to £5,000 

- To build closer collaboration with corporate organisations 

- To increase fundraising events – both our own and encourage supporters 

- To develop a wellness package for patients 

Through these activities, the charity endeavours to strengthen it’s offering to support those living with bowel cancer, and to encourage early screening to increase the chances of treatment. 

**Page 4** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Report of the trustees (incorporating the directors' report) for the period ended 31 December 2025** 

## **Statement of trustees' responsibilities** 

The trustees (who are also directors of Bowel Cancer West for the purpose of company law) are responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice. 

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgements and estimates that are reasonable and prudent; 

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation. 

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and which enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

## **Small company provisions** 

These financial statements have been prepared in accordance with FRS 102 the Financial Reporting Standard applicable in the UK and Republic of Ireland. 

On behalf of the board 

................................. 

Mr John Best 

## **Honorary Treasurer** 

**Page 5** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Independent examiner's report to the trustees on the unaudited financial statements of Bowel Cancer West.** 

We report on the accounts of Bowel Cancer West for the year ended 31 December 2025 set out on pages 2 to 17. 

## **Respective responsibilities of trustees and independent examiner** 

As the charity's trustees you are responsible for the preparation of the accounts, you consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the 2011 Act) and that an independent examination is needed.  It is our responsibility to: 

- examine the accounts under section 145 of the 2011 Act 

- to follow the procedures laid down in the General Directions given by the Charity Commission under 

- section 145(5)(b) of the 2011 Act and 

- to state whether particular matters have come to our attention 

## **Basis of independent examiner's statement** 

Our examination was carried out in accordance with the General Directions given by the Charity Commission.  An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below. 

## **Independent examiner's statement** 

In connection with my examination, no matter has come to my attention: 

- (i) which gives us reasonable cause to believe that in any material respect the requirements: 

   - to keep proper accounting records in accordance with section 130 of the 2011 Act; and 

   - to prepare accounts which accord with the accounting records and to comply with the accounting requirements of the 2011 Act 

have not been met; or 

- (ii) to which, in our opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached. 

........................................................... 

**Mr Chris Jones FMAAT On behalf of Best Accountancy Services (Newton Abbot) Ltd Licensed and regulated by the Association of Accounting Technicians Independent examiner Licence NO:4513** 

**Page 6** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Statement of financial activities (incorporating the income and expenditure account)** 

## **For the period ended 31 December 2025** 

|**Unrestricted**<br>**funds**<br>**Notes**<br>**£**<br>**Incoming resources**<br>Incoming resources from generating funds:<br>Voluntary income<br>2<br>45,112<br>Investment income<br>3<br>30<br>Grants received<br>4<br>-<br>_______<br>**Total incoming resources**<br>45,142<br>_______<br>**Resources expended**<br>Charitable activities<br>48,685<br>Governance costs<br>5<br>4,315<br>_______<br>**Total resources expended**<br>53,000<br>_______<br>**Net incoming/(outgoing) resources for the year**<br>**Net income/(expenditure) for the year**<br>(7,858)<br>Total funds brought forward<br>35,469<br>_______<br>**Total funds carried forward**<br>27,611<br>|**2025**<br>**Total**<br>**£**<br>45,112<br>30<br>-<br>_______<br>45,142<br>_______<br>48,685<br>4,315<br>_______<br>53,000<br>_______<br>(7,858)<br>35,469<br>_______<br>27,611<br>|**2024**<br>**Total**<br>**£**<br>81,708<br>22<br>-<br>_______<br>81,730<br>_______<br>75,344<br>4,085<br>_______<br>79,429<br>_______<br>2,301<br>33,169<br>_______<br>35,469<br>|
|---|---|---|



**The notes on pages 13 to 19 form an integral part of these financial statements.** 

**Page 7** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Balance sheet** 

## **as at 31 December 2025** 

|**Notes**<br>**Fixed assets**<br>Tangible assets<br>11<br>**Current assets**<br>Debtors<br>12<br>Cash at bank and in hand<br>**Creditors: amounts falling**<br>**due within one year**<br>13<br>**Net current assets**<br>**Net assets**<br>**Funds**<br>15<br>Unrestricted general funds<br>**Total funds**|**2025**<br>**£**<br>**£**<br>2,764<br>417<br>25,773<br>_______<br>26,190<br>(1,343)<br>_______<br>24,847<br>_______<br>27,611<br>_______<br>27,611<br>_______<br>27,611<br>|**2024**<br>**£**<br>**£**<br>5,205<br>3,300<br>29,238<br>_______<br>32,538<br>(2,274)<br>_______<br>30,264<br>_______<br>35,469<br>_______<br>35,469<br>_______<br>35,469<br>|
|---|---|---|



The Balance Sheet continues on the following page. 

**The notes on pages 13 to 19 form an integral part of these financial statements.** 

**Page 8** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Balance sheet (continued)** 

## **Directors statements required by the Companies Act 2006** 

## **for the year ended 31 December 2025** 

In approving these financial statements as directors of the company we hereby confirm: 

(a) that for the year stated above the company was entitled to the exemption conferred by section 477 of the Companies Act 2006 ; 

(b) that no notice has been deposited at the registered office of the company pursuant to section 476 of the Companies Act 2006 requesting that an audit be conducted for the year ended 31 December 2025. 

(c) that we acknowledge our responsibilities for: 

(i) ensuring that the company keeps proper accounting records which comply with section 386 of the Companies Act 2006, and 

(ii) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit or loss for the year then ended in accordance with the requirements of sections 394 and 395, and which otherwise comply with the provisions of the Companies Act relating to financial statements, so far as applicable to the company. 

The financial statements were approved by the board on 6[th] August 2026 and signed on its behalf by 

**.................................** 

## **Mr M Coleman** 

## **Director** 

**Page 9** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **1. Accounting policies** 

The principal accounting policies are summarised below. The accounting policies have been applied consistently throughout the year and the preceding year. 

## **1.1. Basis of accounting** 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the  Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)  - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.  Bowel Cancer West meets the definition of a public benefit entity under FRS 102.  The trustees consider that there are no material uncertainties about the Charity's ability to continue as a going concern.  The Charity's functional and presentational currency is the pound sterling. 

## **1.2. Incoming resources** 

All incoming resources are included in the statement of financial activities when the charity is entitled to the  income, and the amount can be quantified with reasonable accuracy. The following specific policies are applied to categories of income: 

- Voluntary income is received by way of donations and gifts and is included in full in the Statement of Financial Activities when receivable.  Donated services and facilities are included at the value to the charity where this can be quantified.  The value of   services provided by volunteers has not been included in these accounts.  Investment income is included when receivable. 

## **1.3. Resources expended** 

Expenditure is recognised on an accrual basis as a liability is incurred. Expenditure includes any VAT which  cannot be fully recovered and is reported as part of the expenditure to which it relates. 

Costs of generating funds comprise the costs associated with attracting voluntary income and the costs of trading  for fundraising purposes including the charity's shop.  Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.  Governance costs include those costs associated with meeting the constitutional and statutory requirements of the charity and include the costs linked to the strategic management of the charity. 

**Page 10** 



**Bowel Cancer West (A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **1.4. Tangible fixed assets and depreciation** 

Tangible fixed assets are stated at cost less accumulated depreciation. Depreciation is provided at rates calculated  to write off the cost less residual value of each asset over its expected useful life, as follows: 

Fixtures, fittings and equipment - 25% of net book value per annum Leasehold – 20% straight line 

## **1.5. Investment Policy** 

The income is held in a business current account and business reserve account with Natwest Bank.  All transactions and business costs are free of  charge and there is no interest paid on the account balance. 

## **1.6. Defined contribution pension schemes** 

The pension costs charged in the financial statements represent the contribution payable by the company during  the year. 

## **2. Voluntary income** 

|Online Just Giving<br>Donations<br>Fundraising<br>Collection tins<br>Events<br>Goods sold<br>Charity Shop Income<br>Other Trading Income|**2025**<br>**Total**<br>**£**<br>7,450<br>5,041<br>7,755<br>279<br>16,339<br>1,027<br>4,172<br>3,049<br>_______<br>45,112<br>|**2024**<br>**Total**<br>**£**<br>8,845<br>11,639<br>19,591<br>316<br>17,540<br>129<br>21,636<br>2,012<br>|
|---|---|---|
|||_______<br>81,708<br>|



**Page 11** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **3. Investment income** 

|Bank interest receivable<br>**nts**<br>Grants received|**2024**<br>**Total**<br>**£**<br>30<br>_______<br>30<br>_______<br>**2025**<br>**Total**<br>**£**<br>-<br>_______<br>-<br>|**2024**<br>**Total**<br>**£**<br>22<br>|
|---|---|---|
|||_______<br>22<br>|
|||_______<br>**2024**<br>**Total**<br>**£**<br>-<br>|
|||_______<br>-<br>|



## **4. Grants** 

**Page 12** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **5. Governance costs** 

|Accountancy and payroll fees<br>Depreciation<br>**6. Net outgoing resources for the year**<br>Net outgoing resources is stated after charging:<br>Depreciation and other amounts written off tangible fixed assets|**2025**<br>**Total**<br>**£**<br>1,874<br>2,441<br>_______<br>4,315<br>_______<br>**2025**<br>**£**<br>2,441<br>|**2024**<br>**Total**<br>**£**<br>1,591<br>2,494<br>|
|---|---|---|
|||_______<br>4,085<br>|
|||_______<br>**2024**<br>**£**<br>2,494|



**Page 13** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **7. Employees** 

|**Employment costs**<br>Wages and salaries<br>Pension costs|**2025**<br>**£**<br>23,955<br>316<br>_______<br>24,271<br>|**2024**<br>**£**<br>33,299<br>436<br>_______<br>33,735<br>|
|---|---|---|



No employee received emoluments of more than £60,000 (2024: None) 

## **8. Number of employees** 

The average monthly numbers of employees (including the trustees) during the year, calculated on the basis of full-time equivalents, was as follows: 

|**2025**<br>**Number**<br>10<br>|**2024**<br>**Number**<br>12<br>|
|---|---|



## **9. Pension costs** 

The company operates a defined contribution pension scheme in respect of the employee. The scheme and its assets are held by independent managers. The pension charge represents contributions due from the company and amounted to £316 (2024 - £436). 

|Pension charge|**2025**<br>**£**<br>316<br>|**2024**<br>**£**<br>436<br>|
|---|---|---|



**Page 14** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **10. Taxation** 

The charity's activities fall within the exemptions afforded by the provisions of the Income and Corporation Taxes Act 1988. Accordingly, there is no taxation charge in these accounts. 

|**Fixtures,**<br>**11.**<br>**Tangible fixed assets**<br>**Leasehold**<br>**fittings and**<br>**equipment**<br>**£**<br>**Cost**<br>At 1 January 2025 and                                                         11,399             5,828<br>At 31 December 2025<br>11,399<br>5,828<br>_______<br>_______<br>**Depreciation**<br>At 1 January 2025<br>6,839<br>5,183<br>Charge for the year<br>2,280<br>161<br>_______<br>_______<br>At 31 December 2025<br>9,119<br>5,344<br>_______<br>_______<br>**Net book values**<br>At 31 December 2025<br>2,280<br>484<br>_______<br>_______<br>At 31 December 2024<br>4,560<br>645<br> <br>|**Fixtures,**<br>**11.**<br>**Tangible fixed assets**<br>**Leasehold**<br>**fittings and**<br>**equipment**<br>**£**<br>**Cost**<br>At 1 January 2025 and                                                         11,399             5,828<br>At 31 December 2025<br>11,399<br>5,828<br>_______<br>_______<br>**Depreciation**<br>At 1 January 2025<br>6,839<br>5,183<br>Charge for the year<br>2,280<br>161<br>_______<br>_______<br>At 31 December 2025<br>9,119<br>5,344<br>_______<br>_______<br>**Net book values**<br>At 31 December 2025<br>2,280<br>484<br>_______<br>_______<br>At 31 December 2024<br>4,560<br>645<br> <br>|**Fixtures,**<br>**11.**<br>**Tangible fixed assets**<br>**Leasehold**<br>**fittings and**<br>**equipment**<br>**£**<br>**Cost**<br>At 1 January 2025 and                                                         11,399             5,828<br>At 31 December 2025<br>11,399<br>5,828<br>_______<br>_______<br>**Depreciation**<br>At 1 January 2025<br>6,839<br>5,183<br>Charge for the year<br>2,280<br>161<br>_______<br>_______<br>At 31 December 2025<br>9,119<br>5,344<br>_______<br>_______<br>**Net book values**<br>At 31 December 2025<br>2,280<br>484<br>_______<br>_______<br>At 31 December 2024<br>4,560<br>645<br> <br>|**Total**<br>**£**<br>17,277<br>17,227<br>_______<br>12,022<br>2,441<br>_______<br>14,463<br>_______<br>2,764<br>_______<br>5,205<br>|
|---|---|---|---|
||_______<br>6,839<br>2,280<br>_______<br>9,119<br>_______<br>2,280<br>_______<br>4,560<br>|_______<br>5,183<br>161<br>_______<br>5,344<br>_______<br>484<br>_______<br>645<br>||



**Page 15** 



## **Bowel Cancer West (A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **12. Debtors** 

|Trade debtors<br>Other debtors<br>Prepayments<br>Other debtors – rent deposit<br>**13.**<br>**Creditors: amounts falling due**<br>**within one-year**<br>Trade creditors<br>Other taxes and social security<br>Pension creditors<br>Accruals and deferred income|**2025**<br>**£**<br>-<br>147<br>270<br>-<br>_______<br>417<br>_______<br>**2025**<br>**£**<br>-<br>136<br>-<br>1,207<br>_______<br>1,343<br>|**2024**<br>**£**<br>-<br>335<br>1,965<br>1,000<br>_______<br>3,300<br>_______<br>**2024**<br>**£**<br>-<br>93<br>98<br>2,081<br>_______<br>2,272<br>|
|---|---|---|



**Page 16** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

## **Notes to the financial statements for the period ended 31 December 2025** 

## **14. Analysis of net assets between funds** 

|Fund balances at 31 December 2025 as represented by:<br>Tangible fixed assets<br>Current assets<br>Current liabilities<br>**15.**<br>**Unrestricted funds**<br>**1**<br>General Funds|**Unrestricted**<br>**Total**<br>**funds**<br>**funds**<br>**£**<br>**£**<br>2,764<br>2,764<br>26,190<br>26,190<br>(1,343)<br>(1,343)<br>_______<br>_______<br>27,611<br>27,611<br>_______<br>_______<br>**At**<br>**At**<br>**January**<br>**Incoming**<br>**Outgoing 31 December**<br>**2025**<br>**resources**<br>**resources**<br>**2025**<br>**£**<br>**£**<br>**£**<br>**£**<br>35,469<br>45,142<br>53,000<br>27,611<br> <br> <br> <br>|**Total**<br>**funds**<br>**£**<br>2,764<br>26,190<br>(1,343)<br>|
|---|---|---|
|||_______<br>27,611<br>|



## **16. Contingent liabilities** 

There were no contingent liabilities at the balance sheet date. 

**Page 17** 



## **Bowel Cancer West** 

## **(A company limited by guarantee)** 

**The following pages do not form part of the statutory accounts.** 



## **Bowel Cancer West (A company limited by guarantee)** 

|**Incoming resources**<br>_Voluntary income_<br>Online Just Giving<br>Donations<br>Fundraising<br>Collection tins<br>Events<br>Goods Sold<br>Charity Shop Income<br>Other trading income<br>**Other Incoming resources**<br>Grants received<br>_Investment income_<br>Bank interest receivable<br>**Total incoming resources**|**2025**<br>**£**<br>7,450<br>5,041<br>7,755<br>279<br>16,339<br>1,027<br>4,172<br>3,049<br>_______<br>45,112<br>_______<br>**2025**<br>**£**<br>-<br>_______<br>**2025**<br>**£**<br>30<br>_______<br>30<br>_______<br>45,142<br>|**2024**<br>**£**<br>8,845<br>11,639<br>19,591<br>316<br>17,540<br>129<br>21,636<br>2,012<br>_______<br>81,708<br>_______<br>**2024**<br>**£**<br>-<br>_______<br>-<br>**2024**<br>**£**<br>22<br>_______<br>22<br>_______<br>81,730<br>|
|---|---|---|





## **Bowel Cancer West (A company limited by guarantee)** 

## **Charitable activities** 

## **Activity 1** 

|_Activities undertaken directly_<br>Wages and salaries<br>Pension costs<br>Online Just Giving fees<br>Promotional and marketing<br>Website<br>Event costs<br>Rent & Rates<br>Light & Heat<br>Charitable Shop Costs<br>BCW Administration<br>Public Liability Insurance<br>Pension Charges<br>Bank & Paypal Charges<br>Training and workshops<br>**Total charitable activity expenditure**<br>**Governance costs**<br>_Activities undertaken directly_<br>Accountancy and payroll fees<br>Depreciation<br>**Total governance costs**<br>**Net incoming/(outcoming) resources for the year**|23,955<br>316<br>216<br>5,464<br>2,451<br>6,447<br>6,991<br>1,414<br>38<br>253<br>535<br>120<br>24<br>461<br>_______<br>1,874<br>2,441<br>_______||48,685<br>______<br>48,685<br>______<br>4,315<br>_______<br>4,315<br>_______<br>(7,858)<br>|33,299<br>436<br>216<br>11,404<br>2,008<br>7,256<br>12,993<br>1,291<br>489<br>4,508<br>985<br>180<br>34<br>245<br>_______<br>1,591<br>2,494<br>_______|75,344<br>_______<br>75,344<br>_______<br>4,085<br>_______<br>4,085<br>_______<br>2,301<br>|
|---|---|---|---|---|---|
|||_<br>||||
|||_||||



